Edigene, A Global Biotechnology Company Focused On Translating Gene-Editing Technologies Into Transformative Therapies For Patients With Serious Genetic Diseases And Cancer, Announced A Research And Development Collaboration With Haihe Laboratory Of Cell Ecosystem To Develop Hematopoietic Stem Cell Regenerative Therapies And Platform Technology By Combining Resources And Expertise From Both Sides.The Haihe Laboratory Of Cell Ecosystem, Run By The Institute Of Hematology And Blood Diseases Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College, Is Focused On Conducting Fundamental Research, Innovation, And Translation In The Cell Ecosystem.Under The Agreement, Both Parties Will Jointly Develop Hematopoietic Stem Cell Regenerative Therapies, Including The Development Of Innovative Genetically-Modified Hematopoietic Stem Cell Therapies And The Exploration Of Novel Biomarkers To Optimize Quality Control For Stem Cell Production.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!